financetom
Business
financetom
/
Business
/
Krystal Biotech Insider Sold Shares Worth $8,889,525, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Krystal Biotech Insider Sold Shares Worth $8,889,525, According to a Recent SEC Filing
Mar 14, 2025 12:44 AM

03:25 AM EDT, 03/14/2025 (MT Newswires) -- Krish S Krishnan, 10% Owner, Director, President and Chief Executive Officer, on March 13, 2025, sold 50,000 shares in Krystal Biotech ( KRYS ) for $8,889,525. Following the Form 4 filing with the SEC, Krishnan has control over a total of 3,136,767 common shares of the company, with 1,533,056 shares held directly and 1,603,711 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1711279/000129870925000004/xslF345X05/wk-form4_1741903456.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Westwater Resources to Sell Convertible Notes in Public Offering
Westwater Resources to Sell Convertible Notes in Public Offering
Jun 13, 2025
07:28 AM EDT, 06/13/2025 (MT Newswires) -- Westwater Resources ( WWR ) said Friday it has agreed to sell convertible notes for up to $5 million to certain institutional investors in a registered public offering. The notes will be convertible into the company's common shares, according to a regulatory filing. ...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
BioCryst Pharmaceuticals Receives Approval for Orladeyo in Colombia
BioCryst Pharmaceuticals Receives Approval for Orladeyo in Colombia
Jun 13, 2025
07:25 AM EDT, 06/13/2025 (MT Newswires) -- BioCryst Pharmaceuticals ( BCRX ) said Friday that Colombia's National Institute of Drug and Food Surveillance has approved Orladeyo to prevent hereditary angioedema attacks in patients at least 12 years old. The company said it has an exclusive collaboration with Pint Pharma for Orladeyo in the pan-Latin America region, with Pint in charge...
Roots Q1 Net Loss Narrows, But Misses Forecast; Revenue Rises
Roots Q1 Net Loss Narrows, But Misses Forecast; Revenue Rises
Jun 13, 2025
07:30 AM EDT, 06/13/2025 (MT Newswires) -- Roots (ROOT.TO) on Friday said its first-quarter net loss narrowed, coming in slightly below forecasts, as revenue increased. The clothing retailer said the net loss shrunk to $7.9 million, or $0.20 per share, from $8.9 million, or $0.22 per share, in the prior year period. The result was slightly below the consensus analyst...
Copyright 2023-2026 - www.financetom.com All Rights Reserved